Thomas Weisel Partners Thermo Fisher Strengthens PCR Portfolio with $260M Fermentas Acquisition Premium Thomas Weisel Partners called Thermo Fisher's planned $260 million acquisition of Fermentas a "synergistic tuck-in deal" that "bolsters Thermo's capabilities in the high-growth PCR market." Cepheid Shares Downgraded by Bank An investment analyst downgraded the shares to "market perform," citing the current hospital spending environment. Bank Ups 2010 Revenue, EPS Estimates for Waters The investment bank upped its estimates for the firm, citing a recent meeting with executives who said that they continue to see a stabilization in end markets. Helicos Cuts Q3 Net Loss by Almost 40 Percent; Rules out Potential Sale of Company Helicos said that based on its "improving standalone prospects and current market valuation" that it has disengaged from discussions involving a potential sale of the company. Majority of Proteomic Stimulus Winners Not Likely to Buy Equipment, Analyst Report Finds Premium A Thomas Weisel Partners report found that some researchers do not plan to use the stimulus cash to buy equipment, such as mass specs. Rather, a majority said they would use the cash to hire additional personnel. Apr 8, 2009 Investment Bank Reports Advantage of CLIA Labs in Driving Adoption of OncotypeDX Premium Apr 3, 2009 Analyst Sees Stimulus Countering Funding Weakness Late in '09 Feb 27, 2009 Beckman Coulter to Issue $500M in New Debt for Olympus Dx Acquisition Feb 6, 2009 Millipore Buys Guava for $22.6M; Aims to Bring Integrated Cell-Analysis Tool to Benchtop Premium Feb 3, 2009 Affy Hopes Rx-Development Apps, New Platform Will Drive Growth After 'Tough' 2008 Premium Breaking News Lunaphore Technologies, University of Bern Partner on Colorectal Cancer Study People in the News: New Appointments at Biocept, Novacyt, Centogene, Illumina, More In Brief This Week: Sophia Genetics, Twist Bioscience, Dante Labs, MGI, Codex DNA, More New Products Posted to GenomeWeb: SpeeDx, Bio-Techne, NuProbe, More DiaSorin Q2 Revenues Rise 20 Percent on SARS-CoV-2 Testing Demand Cepheid Gets $28M From BARDA for SARS-CoV-2 Tests The Scan Interfering With Invasive Mussels The Chicago Tribune reports that researchers are studying whether RNA interference- or CRISPR-based approaches can combat invasive freshwater mussels. Participation Analysis A new study finds that women tend to participate less at scientific meetings but that some changes can lead to increased involvement, the Guardian reports. Right Whales' Decline A research study plans to use genetic analysis to gain insight into population decline among North American right whales, according to CBC. Science Papers Tie Rare Mutations to Short Stature, Immunodeficiency; Present Single-Cell Transcriptomics Map In Science this week: pair of mutations in one gene uncovered in brothers with short stature and immunodeficiency, and more.